ArticleBone2016

SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice.

Kathryn M Thrailkill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.